Back to Results
First PageMeta Content



Pulmonx Gets FDA Nod for U.S. Trial of Emphysema Therapy IDE for Study of Zephyr® Endobronchial Valve Approved August 27, 2012, Redwood City, CA, USA, Pulmonx, an emerging leader in interventional pulmonology, announced
Add to Reading List

Document Date: 2015-03-17 03:09:18


Open Document

File Size: 82,03 KB

Share Result on Facebook
UPDATE